Alpine Global Management’s Pfizer PFE Stock Holding History

Alpine Global Management’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-29,723	Closed	-$832K	–	386
2024 Q2	$832K	Buy	+29,723	New	+$818K	0.14%	124
2022 Q2	–	Sell	-63,660	Closed	-$3.3K	–	608
2022 Q1	$3.3K	Buy	+63,660	New	+$3.3M	0.75%	27
2020 Q4	–	Sell	-68,483	Closed	-$2.38M	–	283
2020 Q3	$2.38M	Buy	68,483 +26,753	+64%	+$938K	0.49%	31
2020 Q2	$1.29M	Buy	+41,730	New	+$1.42M	0.23%	75
2018 Q1	–	Sell	-20,002	Closed	-$687K	–	173
2017 Q4	$687K	Buy	20,002 +12,681	+173%	+$432K	0.16%	73
2017 Q3	$248K	Buy	+7,321	New	+$235K	0.07%	160
2017 Q2	–	Sell	-43,644	Closed	-$1.42M	–	281
2017 Q1	$1.42M	Buy	43,644 +14,503	+50%	+$457K	0.37%	65
2016 Q4	$898K	Buy	+29,141	New	+$890K	0.42%	58
2015 Q3	–	Sell	-51,151	Closed	-$1.63M	–	617
2015 Q2	$1.63M	Sell	51,151 -10,360	-17%	-$338K	0.27%	57
2015 Q1	$2.03M	Sell	61,511 -87,468	-59%	-$2.78M	0.66%	28
2014 Q4	$4.4M	Buy	+148,979	New	+$4.27M	0.79%	24
2014 Q1	–	Sell	-79,050	Closed	-$2.3M	–	175
2013 Q4	$2.3M	Buy	+79,050	New	+$2.3M	3.71%	7

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Alpine Global Management's PFE Position: Q3 2024 in Review

Alpine Global Management sold out of Pfizer (PFE) in Q3 2024, closing a stake of 29,723 shares — an estimated $832K sold.

Alpine Global Management first reported a position in PFE in Q4 2013 and held it in 12 quarters. The position peaked at $4.4M in Q4 2014. 2,909 funds tracked by Wall St. Rank hold PFE as of Q3 2024.

Alpine Global Management reported no remaining Pfizer position as of Q3 2024 after selling out during the quarter.
Alpine Global Management sold 29,723 Pfizer shares in Q3 2024, an estimated $832K.
Alpine Global Management first reported a position in Pfizer in Q4 2013 and held it in 12 quarters.
Alpine Global Management's Pfizer position peaked at $4.4M in Q4 2014.
2,909 funds tracked by Wall St. Rank held Pfizer as of Q3 2024.

Based on Alpine Global Management's 13F filing for Q3 2024, filed 14 Nov 2024.